Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer ( 
BALB/cHeA. Some CcS/Dem strains received the alleles from the susceptible strain STS/A at one or more of the multiple colon tumor susceptibility loci and are susceptible, whereas others are resistant. Linkage analysis shows that these susceptibility genes are different from the mouse homologs of the genes known to be somatically mutated in human colon cancer (KRAS2, TP53, DCC, MCC, APC, MSH2, and probably also MLHJ). Different subsets of genes control tumor numbers and size. Two colon cancer susceptibility genes, Sccl and Scc2, map to mouse chromosome 2. The Sccl locus has been mapped to a narrow region of 2.4 centimorgans (90% confidence interval).
Colon cancer is influenced by environmental factors as well as multiple genetic factors (1) . A number of genes have been found somatically mutated in colon cancer, including the oncogene KRAS2 and the tumor suppressor genes APC, TP53, DCC, and possibly MCC (2) .
Germ-line mutation in theAPC gene causes familial adenomatous polyposis (3, 4) . Some families of hereditary nonpolyposis colon cancer have been found to carry mutations in the MSH2 gene (5) . Subsequently, it turned out that germ-line mutations in mismatch repair genes including also MLHJ, PMSJ, and PMS2 are responsible for most cases of hereditary nonpolyposis colon cancer (6) , and somatic mutations in these genes were found also in sporadic colon cancer (7) . Interestingly, the Li-Fraumeni syndrome, caused by germ-line TP53 mutations, is only weakly associated with colon tumors (8) . As >90% of cases of colon cancer are sporadic and theoretical considerations suggest that a large part of them may occur in genetically susceptible individuals without obvious familial occurrence (9, 10) , the genes possibly influencing the susceptibility to sporadic colon cancer may be of considerable interest.
Inbred strains of mice differ widely in susceptibility to 1,2-dimethylhydrazine (DMH)-induced colon tumors (11) , due to multiple nonlinked genes (12) . To map these genes we used the CcS/Dem (CcS) series of 20 homozygous recombinant congenic strains, derived from the parental strains BALB/cHeA (BA LB/c) (relatively resistant to DMH-induced colon adenomas) and STS/A (STS) (susceptible) (13) . Each CcS strain contains a random subset of about 12.5% of genes from STS, whereas the rest of the genome comes from
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BALB/c. This led to separation of nonlinked colon tumor susceptibility genes of STS in individual CcS strains (14) . As a result, the CcS strains that received such susceptibility gene(s) from STS are highly susceptible to colon adenomas, whereas others are relatively resistant (13) . The BALB/c-and STSderived segments in each of the 20 CcS strains were identified (13, (15) (16) (17) .
Previously we found linkage of a colon tumor susceptibility gene, Sccl (ausceptibility to colon cancer 1), to mouse chromosome 2 (18) . In this study we tested whether the difference in tumor susceptibility between the strains BALB/c and STS is caused by oncogenes, tumor suppressor genes, or mismatch repair genes, presently known to be mutated in colon cancer. In addition, we demonstrated a second colon tumor susceptibility gene, Scc2, linked to Sccl, and tested whether these tumor susceptibility genes can be mapped precisely.
MATERIALS AND METHODS
Mouse Strains and Genetic Crosses. The CcS strains (14) and their genetic composition have been described (13, (15) (16) (17) .
BALB/c x (BALB/c x CcS)Fl backcross mice were produced by crossing several (BALB/c x CcS)Fl males with BALB/c females. For each backcross population, the F1 males had one common male parent of the particular CcS strain.
Recombinants in the Sccl region were produced as follows. BALB/c females were mated with a CcS-19 male, and the F1 hybrids were used to produce (BALB/c x CcS-19)F2 mice. The F2 mice with a recombination in the Hc-Ill segment of chromosome 2 were crossed with BALB/c to produce F2N1 mice. F2N2 and F2N3 generations were produced by further backcrossing with BALB/c females.
Genetic Markers. The DNAs were isolated from tails or tumors as described (19) . The oligonucleotides for the microsatellite loci (20) locus, all these strains were tested. The susceptible strains CcS-5, -11, and -17 received the alleles of all of these genes from the resistant parent BALB/c. Hence, these genes could not be responsible for the susceptibility of these strains. The susceptible strains CcS-3, -4, -7, -16, -18, and -19 received the alleles of one or more of these genes from the susceptible strain STS. However, in backcrosses of the strains CcS-3, -7, -16, and -19 with BALB/c, no association was found between tumor multiplicity and the presence of the region containing these genes from STS ( Table 2 ). In addition to data in Table 2 
Kras2 was typed using the marker D6MitJ4, located near Kras2, the Mlhl region using (a Boldfaced italic type indicates that in these strains strong linkage has been found between that marker and the number of tumors (P < 0.0001). Underlining indicates a distortion in the frequency of heterozygosity for these markers in CcS-16 (D2Ndsl, Cd44: 74%; D2Mit42: 72%). Nevertheless, there is strong evidence for a tumor susceptibility locus near D2Ndsl: P value is 0.0001, using Bonferroni's correction method, taking into account all markers and ignoring correlations. No linkage was found between any of these markers and the size of the tumors. Cd44 was typed using a 0.4-kb fragment encoding rat Cd44 transmembrane region detecting a HindIII restriction fragment length polymorphism (RFLP) (BALB/c, 5.1 kb; STS, 2.5 kb) or using the polymerase chain reaction with the primer pair D2Nki1F influencing susceptibility in mice with ApcMin mutations (27) , because the susceptible CcS strains tested here carry the BALB/c alleles of markers located in this region. Moreover, the only strain (CcS-10) that carries the STS alleles of the markers D4Mit7O and D4Mitl3 (17) (Fig. 2) . The corresponding Hc-lll segment on the other chromosome 2 was in 12 recombinants from STS and in 17 recombinants from BALB/c, and 5 mice had a recombination in both chromosomes. Hence, a total of 39 independent recombinant haplotypes were found, which could be divided into 13 classes according to the crossover sites within the Sccl region (Fig. 2) . Each recombinant was crossed with BALB/c, and their progeny were tested for susceptibility to DMHinduced colon tumors. Approximately half of the mice from the offspring of each individual recombinant carried the recombinant chromosome 2. The progeny of the 5 mice carrying a recombination in both chromosomes all carry one recombinant chromosome 2 and one chromosome 2 from the resistant parent BALB/c.
In the first step of fine mapping Sccl, the tumor multiplicity of the offspring carrying a particular recombinant chromosome 2 was compared with that of their littermates that did not carry a recombinant chromosome and should be either susceptible (heterozygous for the whole Sccl region) or resistant (only BALB/c alleles present). This analysis indicated that the recombinants of the classes 4, 6, 8, 9 , and 11 were susceptible. In most recombinants of the classes 5, 7, and 10, the nonrecombinant chromosome 2 was of STS origin; the progeny tests revealed no difference in susceptibility between the recombinant and the nonrecombinant chromosome, which is compatible with these recombinants being susceptible as well.
To map Sccl to a narrow interval, we determined the genotype and the susceptibility to colon tumors of two subsequent generations of potentially informative recombinants (Fig. 2) . Since in the course of backcrossing further recombination occurred, more detailed information about the role of individual regions of chromosome 2 was obtained. Ordinary Proc. Natl. Acad. Sci. USA 93 (1996) the susceptibility of these strains to colon tumors. These data together indicate that genes other than those known to be somatically mutated in colon tumors are responsible for the difference in colon tumor susceptibility between BALB/c and STS. Although these data are based on two inbred strains only, the fact that not a single one of these seven genes has a significant role in tumor susceptibility indicates that these genes as a group either are not polymorphic or do not have a measurable effect. It is possible that in the future one or several of these genes may be found to influence colon tumor susceptibility in other strains. However, it is very likely that the presently largely unknown Scc genes, such as the ones segregating in the BALB/c-STS cross, will account for a large part of genetic differences in colon tumor susceptibility in mice. Recently, using other strains, a colon tumor susceptibility locus has been mapped to mouse chromosome 12 (31 In the strain CcS-19 the fragment inherited from STS is interrupted by a BALB/c-derived segment between D2Mit9 and D2Mit94. The LOD-2 support interval probably includes this segment, and hence the Sccl region may be <7.7 cM. Within this region, the most likely location of Sccl (90% confidence interval) is a 2.4 cM region around D2Mit66. Sccl is also present in the strain CcS-16, which only inherited the STS alleles of the markers located telomerically from D2Mit66. Although this strain may carry a very short undetected STS segment centromerically from D2Mit66, it is more likely that Sccl maps telomerically from D2Mit66. This implies that the estimated Sccl region is <1 cM long.
In conclusion, we have shown that susceptibility to DMHinduced colon tumors in mice is largely determined by genes other than those found somatically mutated in colon cancer and that these genes can be mapped with high precision. This opens the way to their positional cloning, as well as to the study of their function in the carcinogenic process.
